Northeast Health Services Expands Services with Spravato® Treatment at Lowell, MA Clinic
Northeast Health Services in Lowell now offers Spravato®, a fast-acting, FDA-approved treatment for treatment-resistant
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.
Northeast Health Services in Lowell now offers Spravato®, a fast-acting, FDA-approved treatment for treatment-resistant depression.
LOWELL, MA, UNITED STATES, September 9, 2026 /EINPresswire.com/ — Northeast Health Services is proud to announce the availability of Spravato® nasal spray at its Lowell clinic. This cutting-edge treatment offers new hope for individuals struggling with treatment-resistant depression, providing a fast-acting option that is both effective and FDA-approved.
Spravato®, also known as esketamine, is a fast-acting treatment, with clients often feeling relief from their depression symptoms within hours. It works by rapidly altering brain chemistry to provide relief from symptoms such as sadness, hopelessness, and loss of interest in activities. Historically Spravato® has been used in conjunction with an oral antidepressant; however, new FDA approval allows use of Spravato® without a concurrent oral antidepressant. Administered under the careful supervision of experienced healthcare professionals, Spravato® ensures safe and effective care for those who need it.
Spravato® is now more accessible than ever and is available at several Northeast Health Services clinics throughout Massachusetts.
In a short-term study, patients treated with Spravato® combined with an oral antidepressant experienced a faster and more significant reduction in depression symptoms after just 4 weeks, compared to those who received the placebo alongside an oral antidepressant (https://www.spravato.com/how-spravato-could-help/). This innovative treatment option has been shown to be effective for many individuals who have not responded well to traditional antidepressant medications or talk therapy alone. Spravato® is not a cure for depression, but it can provide significant relief from symptoms and help individuals regain their quality of life.
The addition of Spravato® treatment in Lowell underscores Northeast Health Services’ continued commitment to advancing mental health outcomes through proven, science-backed solutions. By combining cutting-edge treatments with compassionate care, the organization ensures clients receive the highest standard of support tailored to their unique needs.
To learn more about Northeast Health Services and its array of mental health services including individual and group therapy, TMS therapy, medication management, and Spravato® treatment, visit https://nehs.transformationsnetwork.com/schedule-appointment/. To schedule a new client appointment or to discuss how mental health treatment can benefit you, a loved one, or your patients, call 413-846-1848 or visit https://nehs.transformationsnetwork.com/schedule-appointment/.
About Northeast Health Services and Transformations Care Network
Northeast Health Services is a proud member of Transformations Care Network (TCN). As a member of TCN, the Northeast Health Services team can accept more insurance plans and have access to cutting edge services and technological advancements. TCN provides the support, resources, and tools that your care team needs to transform lives in their communities. To learn more about Transformations Care Network, a family of outpatient mental health organizations, and the inspiring work they are doing to shape the future of mental health care, visit www.transformationsnetwork.com.
Erica McPeek
Transformations Care Network
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
